Does stevia mess with your blood sugar or hormones? A crossover trial says no
In 69 people across normal weight, overweight and type 2 diabetes, a stevia drink behaved like water — no shift in glucose, insulin, gut hormones, appetite or how much they ate next.
A recurring worry about non-nutritive sweeteners is that, even though they carry no sugar, they might quietly disturb metabolism — spiking insulin, nudging the hormones that govern appetite, or leading people to eat more later. A crossover trial published in The Journal of Nutrition on 1 September tested that worry for stevia, a plant-based sweetener, and found little to support it [s1].
The claim being tested
The idea that a sweet taste without calories could still trigger a hormonal or appetite response is plausible on its face, and it is the mechanism behind a lot of sweetener anxiety. The authors note that the acute effects of stevia on blood glucose and hormonal responses have not been fully investigated — which is the gap this study set out to fill [s1].
What they did
The trial enrolled three cohorts of 23 people each — with normal weight, with overweight, and with type 2 diabetes — for a total of 69 participants [s1]. In a randomised-sequence crossover design, each person completed four test conditions: a drink with stevia (75.6 mg of steviol equivalents), water, glucose (30 g), and stevia combined with glucose (30 g glucose plus 75.6 mg steviol equivalents) [s1].
Blood was sampled before and for 180 minutes after each drink [s1]. The researchers tracked plasma glucose, insulin, and the gut and pancreatic hormones that regulate blood sugar and appetite — glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1, glucagon and PYY — using the area under the response curve and peak concentrations [s1]. They also measured appetite with visual-analogue scales and, crucially, how much participants ate at a subsequent free-access meal [s1].
The result: stevia looked like water
The response to the stevia drink did not differ significantly from water alone, for any of the three groups [s1]. And when stevia was added to glucose, the combination did not differ significantly from glucose alone [s1] — meaning stevia neither produced a response of its own nor amplified or blunted the body's response to actual sugar.
Appetite ratings and the amount eaten at the later meal were likewise unchanged [s1]. In the authors' summary, acute stevia consumption did not materially alter glycaemia, the hormones involved in glucose and appetite regulation, appetite ratings, or energy intake at a subsequent meal [s1].
What it does and doesn't settle
This is a well-designed acute trial: crossover, randomised in sequence, with each participant serving as their own control across four conditions, and importantly it included people with type 2 diabetes rather than only healthy volunteers [s1]. For the specific fear it addresses — that a single dose of stevia sets off an insulin or appetite reaction — the answer here is reassuringly flat.
The word doing the work is acute. This trial measured the three hours after one drink; it is not a study of what happens when stevia replaces sugar in the diet over months, nor of long-term weight, cardiometabolic or gut-microbiome effects, which are where the larger and less settled debates about sweeteners actually sit. The dose was a defined amount of steviol glycosides in a beverage, not the full range of ways stevia reaches people in processed food. And a null result in 69 people, while informative, is not proof of no effect — only of no effect large enough to show up in this sample.
So the popular claim — that stevia secretly spikes your hormones or blood sugar in the moment — does not hold up in this test. The broader question of how non-nutritive sweeteners affect health when used habitually is a separate one, and this study does not answer it. As with any dietary choice, that is a question to work through with a clinician rather than a single trial.
The trial was prospectively registered on ClinicalTrials.gov (NCT05287906) [s2], and its crossover structure — each participant completing all four drink conditions — is a genuine strength, since it removes the between-person differences that complicate parallel-group comparisons of diet. Even so, a reader should keep the scope in view: this concerns the immediate physiological response to a single, defined dose, and it answers a narrow fear rather than the wider, unsettled question of what habitual sweetener use does over years [s1].
Sources
- Acute Stevia Consumption does not Alter Endocrine Responses in Individuals with Normal Weight, Overweight, and Type 2 Diabetes Mellitus — The Journal of Nutrition, 2026-09-01
- A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release (NCT05287906) — ClinicalTrials.gov
Sources
- Acute Stevia Consumption does not Alter Endocrine Responses in Individuals with Normal Weight, Overweight, and Type 2 Diabetes Mellitus — The Journal of Nutrition , September 1, 2026
- A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release (NCT05287906) — ClinicalTrials.gov
More on
The fibre evidence points at 25 to 29 grams a day. A supplement is not the same thing.
A Lancet series covering 135 million person-years found the largest risk reductions in that range. Trials of isolated fibre supplements produce much smaller effects on much narrower outcomes.
WHO called aspartame a possible carcinogen and left the safe intake unchanged
Two WHO bodies reported on the same day in July 2023 and reached findings that sound contradictory. Both were right, because they were answering different questions.
Ultra-processed food and diabetes risk, tested outside a Western diet
A pooled analysis of 72,776 Korean adults found an 11% higher type 2 diabetes risk in the top intake quartile. An updated meta-analysis of 17 cohorts put the dose-response at 10% per 10% of intake.
Cutting calories on top of a Mediterranean diet lowered diabetes risk by 31%
A Spanish trial in 4,746 adults compared an energy-reduced Mediterranean diet plus exercise against the same diet eaten freely. Over six years the absolute gap was 12.0% versus 9.5%.